Wednesday, April 30th, 2025

Hong Leong Asia Eyes Growth in JS-SEZ, Construction Boom & China Recovery

📈 Strong Earnings & Optimistic Outlook
Hong Leong Asia (HLA) posted a 4.1% y-o-y revenue growth to $4.25 billion in FY2024, while earnings surged 35.3% to $87.8 million, the highest since FY2011. The growth was fueled by a strong order book in its building materials unit (BMU) and higher powertrain sales from its NYSE-listed China Yuchai International. CEO Stephen Ho remains confident about further expansion, despite concerns over China’s economic recovery.


🏗️ Construction Boom Boosts Building Materials Unit (BMU)

With Singapore’s construction industry booming, HLA’s BMU revenue grew 4.9% y-o-y to $682.3 million, with profit after tax rising 13.1% to $86.2 million. The segment, which includes cement, precast concrete, ready-mix concrete (RMC), and quarry products, remains one of the largest building materials suppliers in Singapore.

  • Key Developments in BMU:
    • Singapore’s precast revenues were slower in FY2024 but are expected to rebound in 2025.
    • Johor-Singapore Special Economic Zone (JS-SEZ) will fuel future cement demand in Malaysia.
    • Automation investments and an expanded fleet of 12-cubic-metre concrete mixers will enhance efficiency.
    • The HL-Sunway Prefab Hub, launched in July 2023, can supply precast elements for 2,500 dwelling units annually.

⚙️ Powertrain Growth Amid China’s Slow Recovery

HLA’s China Yuchai International delivered $3.55 billion in revenue (+4.2% y-o-y), with profit after tax climbing 17.2% to $89.6 million. A 13.7% increase in powertrain sales drove these results.

🔹 China’s Recovery Remains Uncertain
CEO Stephen Ho acknowledged China’s sluggish domestic consumption, affecting truck and bus demand. However, he remains optimistic for a rebound, saying, “When logistics and tourism pick up, heavy and medium-duty truck sales should follow.”

🔹 Green Investments for Future Growth
China Yuchai is investing in cleaner energy technologies, including hydrogen engines, batteries, automotive chips, and sensors, to secure long-term sustainability.


💰 Analysts Bullish on HLA’s Future Growth

Analyst Ratings & Target Prices:

  • UOB Kay Hian (Llelleythan Tan & John Cheong): $1.11, revised FY2025-FY2026 PATMI estimates up 2%-3%.
  • DBS (Dale Lai & Derek Tan): Raised target price to $1.60 from $1.28, citing earnings momentum.

🔹 Dividend Surprise: HLA announced a final dividend of 3 cents per share, reinforcing confidence in its financial strength.

🔹 Valuation: Trading at $1.02 per share, HLA has an attractive forward P/B ratio of 0.6x and is set for an earnings CAGR of 15% from FY2024-FY2027.


🚀 Future Outlook: Positioned for Expansion

With a robust construction pipeline, expansion in JS-SEZ, and China Yuchai’s green initiatives, HLA is primed for continued growth. If China’s economy rebounds, truck and engine demand could accelerate, further boosting earnings.
Thank you

“AI Revolution in Healthcare: Top Picks & Trends Transforming China’s Medical Industry 1”

Overview The healthcare sector is at the cusp of transformation as artificial intelligence (AI) revolutionizes every facet of medicine from diagnostics and imaging to drug research and development. This comprehensive report outlines how top...

China Solar Industry Outlook 2025: Challenges and Opportunities Amid Global Shifts

Comprehensive Analysis of China’s Renewable Energy Sector – UOB Kay Hian China’s Solar Energy Sector: Challenges, Opportunities, and Comprehensive Company Insights Report Date: January 24, 2025 Broker Name: UOB Kay Hian Overview of China’s...

Venture Corporation Limited Honored with Prestigious Supplier Excellence Award from Lam Research

Date: 27 September 2024 Broker: Lim & Tan Securities Award Recognition Venture Corporation Limited, priced at $14.16 as of 27 September 2024, received the prestigious Supplier Excellence Award at Lam Research Corporation’s 2024 ceremony....